1. Search Result
Search Result
Results for "

Wee1

" in MedChemExpress (MCE) Product Catalog:

29

Inhibitors & Agonists

3

Recombinant Proteins

3

Oligonucleotides

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-108343

    Wee1 Cancer
    WEE1-IN-4 is a potent checkpoint Wee1 kinase inhibitor with an IC50 of 0.011 μM [1].
    WEE1-IN-4
  • HY-138239

    Wee1 Cancer
    WEE1-IN-3 is a potent Wee1 kinase inhibitor with an IC50 of <10 nM. WEE1-IN-3 has anticancer activities [1].
    WEE1-IN-3
  • HY-147054

    Wee1 CDK Cancer
    WEE1-IN-5 is a potent WEE1 inhibitor with an IC50 value of 0.8 nM. WEE1-IN-5 inhibits phospho-CDC2. WEE1-IN-5 abrogates the G2 check point, increasing sensitivity to DNA damaging agents in cancer cells. WEE1-IN-5 can be used for researching anticancer [1].
    WEE1-IN-5
  • HY-168654

    Wee1 Cancer
    WEE1 degrader 1 (Compound 10) is a Wee1 degrader with a DC50 value of 1.5 nM against Wee1. WEE1 degrader 1 possesses anti-cancer cell proliferation effects [1].
    WEE1 degrader 1
  • HY-RS15805

    Small Interfering RNA (siRNA) Others

    WEE1 Human Pre-designed siRNA Set A contains three designed siRNAs for WEE1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    WEE1 Human Pre-designed siRNA Set A
    WEE1 Human Pre-designed siRNA Set A
  • HY-RS15806

    Small Interfering RNA (siRNA) Others

    Wee1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Wee1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Wee1 Mouse Pre-designed siRNA Set A
    Wee1 Mouse Pre-designed siRNA Set A
  • HY-RS15807

    Small Interfering RNA (siRNA) Others

    Wee1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Wee1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Wee1 Rat Pre-designed siRNA Set A
    Wee1 Rat Pre-designed siRNA Set A
  • HY-168180

    Wee1 Cancer
    WEE1-IN-11 (Compound 13) is a potent CDK2 inhibitor with an IC50 of 2.0 nM. WEE1-IN-11 inhibits NCI–H446, A427, OVCAR3, C33A,and WiDr cells with IC50s of 93.9, 34.5, 86.7, 23.1, and 85 nM, respectively [1].
    WEE1-IN-11
  • HY-161880

    Wee1 Cancer
    WEE1-IN-10 (compound 77) is a Wee1 kinase inhibitor. WEE1-IN-10 shows inhibitory activity on LOVO cell growth, with an IC50 of 0.524 μM. WEE1-IN-10 can be used for the research of diseases caused by abnormal activity of Wee1 [1].
    WEE1-IN-10
  • HY-160530

    Wee1 Cancer
    WEE1-IN-6 (compound 110) is a orally active WEE1 inhibitor with an DC50 value of ≦ 100 nM. WEE1-IN-6 inhibits cell proliferation [1].
    WEE1-IN-6
  • HY-161879

    Wee1 Cancer
    WEE1-IN-9 (Compound 1) is a Wee1 inhibitor that can be used in cancer research [1].
    WEE1-IN-9
  • HY-163697

    Wee1 Apoptosis Cancer
    WEE1-IN-7 (compound 12h) is a potent and orally activeWEE1 inhibitor with an IC50 value of 2.1 nM. WEE1-IN-7 induces apoptosis and cell cycle arrest at the S phase. WEE1-IN-7 shows antitumor activity [1].
    WEE1-IN-7
  • HY-161871

    Wee1 Cancer
    WEE1-IN-8 (Compound 55) is a selective WEE1 inhibitor, with an IC50 of 0.98 nM. WEE1-IN-8 (Compound 55) can be used for the research of Pancreatic cancer, Ovarian cancer, Colorectal cancer, Uterine serous carcinoma, etc [1].
    WEE1-IN-8
  • HY-169946

    Wee1 Cancer
    WEE1/PKMYT1-IN-1 (compound 75) is a potent and orally active WEE1 and PKMYT1 inhibitor. WEE1/PKMYT1-IN-1 shows antiproliferation activity [1].
    WEE1/PKMYT1-IN-1
  • HY-112409

    Others Others
    WEE1-IN-2 is an active compound.
    WEE1-IN-2
  • HY-144999

    Wee1 Cancer
    LEB-03-146 is a WEE1 DUBTAC (deubiquitinase-targeting chimera) linking AZD1775 (Adavosertib) to the OTUB1 recruiter EN523 through a PEG2 linker. LEB-03-146 shows significant WEE1 stabilization in HEP3B hepatoma cancer cells [1].
    LEB-03-146
  • HY-143342

    Wee1 Cancer
    LEB-03-144 is a WEE1 DUBTAC (deubiquitinase-targeting chimera) linking AZD1775 (Adavosertib) to the OTUB1 recruiter EN523 through a C3 alkyl linker. LEB-03-144 shows significant WEE1 stabilization in HEP3B hepatoma cancer cells [1].
    LEB-03-144
  • HY-10993
    Adavosertib
    Maximum Cited Publications
    46 Publications Verification

    AZD1775; MK-1775

    Wee1 Cancer
    Adavosertib (AZD-1775; MK-1775) is a potent Wee1 inhibitor with an IC50 of 5.2 nM.
    Adavosertib
  • HY-143343

    Wee1 Cancer
    LEB-03-153 is a WEE1 DUBTAC (deubiquitinase-targeting chimera) linking AZD1775 (Adavosertib) to the OTUB1 recruiter EN523 through no linker [1].
    LEB-03-153
  • HY-132295
    Azenosertib
    1 Publications Verification

    ZN-c3

    Wee1 Cancer
    Azenosertib (ZN-c3) is a selective, orally active inhibitor for Wee1 inhibitor (IC50=3.9 nM). Azenosertib exhibits antitumor activity [1].
    Azenosertib
  • HY-103029

    Wee1 Cancer
    Bosutinib isomer is a ligand or inhibitor with high binding affinity for both Wee1 and Wee2, with Kd values of 43.7 ± 10.0 and 4.7 ± 2.3 nM, respectively [1].
    Bosutinib isomer
  • HY-10993R

    Wee1 Cancer
    Adavosertib (Standard) is the analytical standard of Adavosertib. This product is intended for research and analytical applications. Adavosertib (AZD-1775; MK-1775) is a potent Wee1 inhibitor with an IC50 of 5.2 nM.
    Adavosertib (Standard)
  • HY-143340

    Wee1 Cancer
    LEB-03-145 is a WEE1 DUBTAC (deubiquitinase-targeting chimera) linking AZD1775 (Adavosertib) to the OTUB1 recruiter EN523 through a C5 alkyl linker [1].
    LEB-03-145
  • HY-13925
    PD0166285
    5+ Cited Publications

    Wee1 Apoptosis Cancer
    PD0166285, a substrate of P-gp, is a WEE1 inhibitor and a weak Myt1 inhibitor with IC50 values of 24 and 72 nM, respectively. PD0166285 exhibits an IC50 of 3.433 μM for Chk1 [1].
    PD0166285
  • HY-13925A

    Wee1 Apoptosis Cancer
    PD0166285 dihydrochloride, a substrate of P-gp, is a WEE1 inhibitor and a weak Myt1 inhibitor with IC50 values of 24 and 72 nM, respectively. PD0166285 dihydrochloride exhibits an IC50 of 3.433 μM for Chk1 [1].
    PD0166285 dihydrochloride
  • HY-18961

    Checkpoint Kinase (Chk) Wee1 Inflammation/Immunology Cancer
    PD 407824 is a checkpoint kinase Chk1 and WEE1 inhibitor with IC50s of 47 and 97 nM, respectively. PD 407824 is a chemical BMP sensitizer and increases the sensitivity of cells to sub-threshold amounts of BMP4 [1] .
    PD 407824
  • HY-133618

    Wee1 PROTACs Cancer
    Pomalidomide-C3-adavosertib is a rapid and selective PROTAC Wee1 degrader (IC50=3.58 nM). Pomalidomide-C3-adavosertib shows anti-cancer cell proliferation activity, and induces apoptosis [1].
    Pomalidomide-C3-adavosertib
  • HY-133702

    PROTAC Linkers Cancer
    Aniline-piperazine-C3-NH-Boc (Compound Int-3) is a PROTAC linker, and can be used for synthesis of Pomalidomide-C3-adavosertib (HY-133618) and AZD1775 (HY-10993) (a Wee1 inhibitor) [1].
    Aniline-piperazine-C3-NH-Boc
  • HY-148065

    PROTACs Cancer
    FMF-06-098-1 is a multitargeted depressant. FMF-06-098-1 can be used to target degradation kinases which degrades AAK1, AΒL2, AURKA, AURKB, BUBIB, CDC7, CDK1, CDK12, CDK13, CDK2, CDK4, CDk6, CDK7, CDK9, CHEK1, CSNKID, EPHA1, PER, FGFR1, GAK, IRAK4, ITK, LIMK2, MAP4K2, MAP4K3, MAPK6, MAPK7, MARK4, MELK, PKN3, PLK4, PRKAA1, PTK2, PTK6, RPS6KA4, S1K2, STK35, TNK2, UHMK1, ULK1, and WEE1 [1].
    FMF-06-098-1

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: